LLY compared with GERN: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

GERNGeron Corp

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

GERNGeron Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

GERN: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only GERN 2

—Tanner Pharmaunlistedsupplier

—Royalty Pharma Development Fundingunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

LLY, solidGERN, dashed

LLYELI Lilly & Co

1,387.36▼−2.16%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

GERNGeron Corp

0.94▼−12.58%

Regular sessionNov 5 '26

Mkt cap$695.8MRevenue$60MQ3 FY26Revenue$184MFY25

Compare

Regular sessionNov 5 '26

LLYELI Lilly & Co

GERNGeron Corp

1,387.36▼−2.16%

Price

0.94▼−12.58%

$1.3T

Mkt cap

$695.8M

Q3 FY26$24.4B

Revenue

$60MQ3 FY26

FY25$65.2B

Revenue

$184MFY25

LLY1,387.36▼−2.16%vsGERN0.94▼−12.58%Regular sessionNov 5 '26